10 Best Performing American Stocks in June 2026
In this article, we will look at the 10 Best Performing American Stocks in June 2026.
Kymera Therapeutics Inc. (KYMR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 8,657,242 | $992,725,940 | 4.97% | |
| 2. | VenBio Select Advisor Kurt Von Emster | 7,474,747 | $857,129,238 | 7.7% | |
| 3. | Biotechnology Value Fund / BVF Inc Mark Lampert | 3,872,052 | $444,008,203 | -30% | 11.35% |
| 4. | Siren L.L.C. Raymond Debbane | 2,935,830 | $336,651,626 | -8% | 6.81% |
| 5. | Driehaus Capital Richard Driehaus | 919,233 | $105,408,448 | -12% | 0.61% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $86.00 | 1,838,621 | $158,121,406.00 | 7,955,916 | 2025-12-11 | Filing | |
| $86.00 | 167,192 | $14,378,512.00 | 701,326 | 2025-12-11 | Filing | |
| $44.00 | 58,780 | $2,586,320.00 | 353,412 | 2025-06-30 | Filing | |
| $44.00 | 115,783 | $5,094,452.00 | 2,219,858 | 2025-06-30 | Filing | |
| $44.00 | 142,604 | $6,274,576.00 | 2,798,795 | 2025-06-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $116.12 | 262 | $30,423.44 | 666,568 | 2026-10-01 | Filing | |
| $115.40 | 8,230 | $949,742.00 | 666,830 | 2026-10-01 | Filing | |
| $114.43 | 7,601 | $869,782.43 | 675,060 | 2026-10-01 | Filing | |
| $113.24 | 4,876 | $552,158.24 | 682,661 | 2026-10-01 | Filing | |
| $112.42 | 5,506 | $618,984.52 | 687,537 | 2026-10-01 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 814 | $90,997 | 0% | |
| 2. | 112 | $12,520 | 0% | |
| 3. | 43 | $4,807 | 0% |
News See All
10 Best AI Driven Biotech Stocks to Invest In
In this article, we will take a look at some of the best AI driven biotech stocks that are currently offering attractive upside potential.
Is Kymera Therapeutics, Inc. (KYMR) a Long-Term Biotech Winner After New Buy Rating and Coverage Launch At Canaccord?
We recently compiled a list of the 8 Best Immunology Stocks to Buy According to Hedge Funds. Kymera Therapeutics, Inc. (NASDAQ:KYMR) is among the best immunology stocks to invest in.
8 Best Immunology Stocks to Buy According to Hedge Funds
In this article, we will be taking a look at the 8 Best Immunology Stocks to Buy According to Hedge Funds.
FDA Grants Fast Track Designation to Kymera Therapeutics, Inc. (KYMR)’s KT-621 for Eosinophilic Asthma
We recently compiled a list of the Top 10 AI-Powered Biotech Stocks to Buy Right Now. Kymera Therapeutics, Inc. is among the best biotech stocks.
Top 10 AI-Powered Biotech Stocks to Buy Right Now
In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Right Now.
15 Most Promising Stocks Under $100 to Buy
In this article, we will discuss the 15 Most Promising Stocks Under $100 to Buy.
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q4 2025 Earnings Call Transcript
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q4 2025 Earnings Call Transcript February 26, 2026Kymera Therapeutics, Inc. misses on earnings expectations.
Kymera Therapeutics, Inc. (KYMR) Up 28% in 3M, Analysts See Further Upside
Kymera Therapeutics, Inc. (NASDAQ:KYMR) is among the 14 best booming stocks to buy right now.
14 Best Booming Stocks to Buy Right Now
This article looks at the 14 Best Booming Stocks to Buy Right Now.
Hedge Fund Resource Center